Price T Rowe Associates Inc Summit Therapeutics Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
239Shares Held
87.2MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$674 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$321 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$218 Million0.0% of portfolio
-
State Street Corp Boston, MA4.85MShares$134 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$90.7 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.55B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...